As of 2024-12-13, the Relative Valuation of Diaceutics PLC (DXRX.L) is (122.40) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 120.00 GBP, the upside of Diaceutics PLC based on Relative Valuation is -202.0%.
The range of the Relative Valuation is (80.15) - (121.46) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.9x - 44.3x | 38.3x |
| Forward P/E multiples | 19.6x - 36.2x | 34.7x |
| Fair Price | (80.15) - (121.46) | (122.40) |
| Upside | -166.8% - -201.2% | -202.0% |
| Date | P/E |
| 2024-12-12 | -36.38 |
| 2024-12-11 | -35.93 |
| 2024-12-10 | -34.74 |
| 2024-12-09 | -34.74 |
| 2024-12-06 | -34.59 |
| 2024-12-05 | -34.74 |
| 2024-12-04 | -34.74 |
| 2024-12-03 | -34.74 |
| 2024-12-02 | -34.89 |
| 2024-11-29 | -35.34 |
| 2024-11-28 | -35.34 |
| 2024-11-27 | -34.59 |
| 2024-11-26 | -34.59 |
| 2024-11-25 | -34.59 |
| 2024-11-22 | -35.04 |
| 2024-11-21 | -35.04 |
| 2024-11-20 | -35.34 |
| 2024-11-19 | -35.49 |
| 2024-11-18 | -35.19 |
| 2024-11-15 | -35.49 |
| 2024-11-14 | -35.78 |
| 2024-11-13 | -36.23 |
| 2024-11-12 | -36.23 |
| 2024-11-11 | -36.23 |
| 2024-11-08 | -36.23 |
| 2024-11-07 | -36.23 |
| 2024-11-06 | -36.23 |
| 2024-11-05 | -36.23 |
| 2024-11-04 | -36.23 |
| 2024-11-01 | -36.23 |
| 2024-10-31 | -36.23 |
| 2024-10-30 | -36.08 |
| 2024-10-29 | -35.04 |
| 2024-10-28 | -36.53 |
| 2024-10-25 | -36.83 |
| 2024-10-24 | -37.72 |
| 2024-10-23 | -37.87 |
| 2024-10-22 | -38.47 |
| 2024-10-21 | -39.36 |
| 2024-10-18 | -39.66 |
| 2024-10-17 | -39.81 |
| 2024-10-16 | -39.96 |
| 2024-10-15 | -39.81 |
| 2024-10-14 | -39.66 |
| 2024-10-11 | -39.66 |
| 2024-10-10 | -39.66 |
| 2024-10-09 | -39.66 |
| 2024-10-08 | -39.81 |
| 2024-10-07 | -39.81 |
| 2024-10-04 | -39.66 |